Survey among healthcare professionals treating patients with metastatic breast cancer in selected European countries to evaluate their knowledge on management of hyperglycemia when using alpelisib

First published 20/07/2021

Last updated 03/06/2025

EU PAS number:

EUPAS42022

Study

Finalised

Documents

Study protocol

Initial protocol

byl719c2005--protocol_12-_Redacted

English (1.76 MB - PDF) View document

Updated protocol

byl719c2005-01--protocol amendment_Redacted.pdf

First published: 07/08/2024

English (2.14 MB - PDF) View document

Study results

Study report

CBYL719C2005_Non-Interventional Study Final Report_V1.0_25Apr2025_23 May 2025_Redacted.pdf

English (9.86 MB - PDF) View document

Other information

Secondary tabs